Compounds > 1,2-dihydro-1,2-dihydroxy-5-methylchrysene
Page last updated: 2024-12-06
1,2-dihydro-1,2-dihydroxy-5-methylchrysene
Description
1,2-dihydro-1,2-dihydroxy-5-methylchrysene is a polycyclic aromatic hydrocarbon (PAH) metabolite. Here's what makes it important for research:
**What it is:**
* **Structure:** It's a derivative of chrysene, a common PAH found in environmental pollutants like coal tar, smoke, and diesel exhaust.
* **Formation:** It's formed in the body when chrysene is metabolized by enzymes called cytochrome P450s. This metabolic process adds two hydroxyl groups (-OH) to the chrysene molecule, resulting in 1,2-dihydro-1,2-dihydroxy-5-methylchrysene.
**Why it's important for research:**
* **Carcinogenesis:** This metabolite is a potent mutagen and carcinogen. It can damage DNA, leading to mutations that can contribute to cancer development. Research focuses on understanding its role in lung cancer and other cancers associated with exposure to PAHs.
* **Biomarker:** The presence of 1,2-dihydro-1,2-dihydroxy-5-methylchrysene in biological samples (like urine or blood) can serve as a biomarker of exposure to chrysene and other PAHs. This information is crucial for assessing the health risks associated with PAH exposure and for developing strategies for prevention and treatment.
* **Metabolic Pathways:** Studying the formation of this metabolite helps researchers understand the metabolic pathways involved in PAH detoxification and the factors influencing their toxicity. This knowledge can be used to develop interventions that target these pathways to minimize the carcinogenic effects of PAHs.
* **Environmental Health:** The research on 1,2-dihydro-1,2-dihydroxy-5-methylchrysene contributes to understanding the environmental health risks posed by PAHs. This knowledge helps in developing regulations and strategies for reducing PAH emissions from various sources, ultimately protecting human health.
**In summary:** 1,2-dihydro-1,2-dihydroxy-5-methylchrysene plays a significant role in research due to its carcinogenic properties, its use as a biomarker of PAH exposure, and its role in elucidating the metabolic pathways associated with PAH detoxification. Understanding this metabolite is vital for assessing health risks, developing preventive measures, and mitigating the harmful effects of PAHs on human health.
1,2-dihydro-1,2-dihydroxy-5-methylchrysene: major active metabolite of 5-methylchrysene; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 49838 |
CHEMBL ID | 3230493 |
MeSH ID | M0067841 |
Synonyms (10)
Synonym |
67411-81-8 |
1,2-dihydroxy-1,2-dihydro-5-methylchrysene |
1,2-dihydro-1,2-dihydroxy-5-methylchrysene |
1,2-chrysenediol, 1,2-dihydro-5-methyl- |
chrysene, 1,2-dihydro-1,2-dihydroxy-5-methyl- |
5-methylchrysene-1,2-dihydrodiol |
5-methyl-1,2-dihydrochrysene-1,2-diol |
CHEMBL3230493 |
1,2-dihydro-1,2-dihydroxy-5-methyl-chrysene |
DTXSID90986687 |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
" These studies show that the relative efficacy of protection by hGSTP1 against mutagenicity of 5MC or 5MC-1,2-diol is in part determined by the specific CYP pathway that catalyzes activation to the toxic or mutagenic metabolites." | ( Cytotoxicity and mutagenicity of 5-methylchrysene and its 1,2-dihydrodiol in V79MZ cells modified to express human CYP1A1 or CYP1B1, in the presence or absence of human GSTP1 coexpression. Ahmad, S; Amin, S; Doehmer, J; Kabler, SL; Morrow, CS; Rudd, L; Townsend, AJ, 2008) | 0.35 |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.98
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.98 (24.57) | Research Supply Index | 2.20 (2.92) | Research Growth Index | 4.18 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |